Inspire Medical Systems Stock-Based Compensation Growth & History (INSP)

Inspire Medical Systems's stock-based compensation was $130.3M for fiscal 2025.

View full Inspire Medical Systems company overview

Inspire Medical Systems annual stock-based compensation history

Inspire Medical Systems annual stock-based compensation

Fiscal yearPeriod endedStock-based compensationChangeGrowth
20252025-12-31$130.3M$14.3M+12.29%
20242024-12-31$116.0M$33.5M+40.67%
20232023-12-31$82.5M$30.5M+58.69%
20222022-12-31$52.0M$25.8M+98.53%
20212021-12-31$26.2M$13.4M+104.24%
20202020-12-31$12.8M$6.6M+106.83%
20192019-12-31$6.2M$5.0M+408.37%
20182018-12-31$1.2M$976,000+401.65%
20172017-12-31$243,000

Inspire Medical Systems stock-based compensation trends

Over the last five fiscal years, Inspire Medical Systems's stock-based compensation increased from $12.8M to $130.3M, a change of $117.4M. The latest reported quarter, Q2 2026, shows $31.2M.

About the metric

What stock-based compensation means

Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.

Calculation and source

SEC-reported stock-based compensation

TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Inspire Medical Systems source filings ↗

Community posts

It’s quiet here.

No posts about INSP yet. Start the conversation.

Write the first post